Chinese Innovative Drug Cipepofol Breaks into Global Market with U.S. FDA Approval

China’s homegrown Class 1 innovative intravenous anesthetic, Cipepofol (CYPSEDO) Injection, developed by Haisco Pharmaceutical Group, has secured marketing approval from the U.S. Food and Drug Administration (FDA), marking a significant….. Subscribe for Full Access! Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years! Subscribe! Key Data Topics anesthesia, China, Cipepofol, clinical studies, drug development, FDA, global market, Haisco Pharmaceutical Group, innovation, Patient Safety, pharmaceuticals Share this Data